Bayesian approach to the assessment of the population-specific risk of inhibitors in hemophilia A patients: a case study

BACKGROUND: Developing inhibitors is a rare event during the treatment of hemophilia A. The multifacets and uncertainty surrounding the development of inhibitors further complicate the process of estimating inhibitor rate from the limited data. Bayesian statistical modeling provides a useful tool in...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Ji, Iorio, Alfonso, Marcucci, Maura, Romanov, Vadim, Pullenayegum, Eleanor M, Marshall, John K, Thabane, Lehana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087814/
https://www.ncbi.nlm.nih.gov/pubmed/27822129
http://dx.doi.org/10.2147/JBM.S103087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087814/
https://www.ncbi.nlm.nih.gov/pubmed/27822129
http://dx.doi.org/10.2147/JBM.S103087

Ejemplares similares